Nymox Pharmaceutical
NYMX
#10319
Rank
A$25.38 M
Marketcap
Country
A$0.28
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -A$3.37 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -A$9.08 Million, an increase over its 2021 earnings that were of -A$17.37 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$3.37 Million-62.89%
2022 -A$9.08 Million-47.71%
2021 -A$17.37 Million6.61%
2020 -A$16.29 Million-10.91%
2019 -A$18.28 Million24.24%
2018 -A$14.72 Million-20.03%
2017 -A$18.4 Million2.71%
2016 -A$17.92 Million-63.86%
2015 -A$49.57 Million674.44%
2014 -A$6.41 Million-6.11%
2013 -A$6.82 Million-35.66%
2012 -A$10.6 Million-20.76%
2011 -A$13.38 Million38.33%
2010 -A$9.67 Million35.59%
2009 -A$7.13 Million11.8%
2008 -A$6.38 Million-12.94%
2007 -A$7.33 Million8.85%
2006 -A$6.73 Million36.5%
2005 -A$4.93 Million-4.4%
2004 -A$5.16 Million-14.58%
2003 -A$6.04 Million
2001 -A$4.43 Million-20.54%
2000 -A$5.58 Million21.72%
1999 -A$4.58 Million-25.56%
1998 -A$6.16 Million101.3%
1997 -A$3.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.67 B-1,552,714.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.17 B-471,733.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.77 B-391,863.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$35.79 B-1,190,803.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$1.83 B-61,090.28%๐Ÿ‡บ๐Ÿ‡ธ USA